Articles Israerl Research and Development.
Home / About Us / Press Materials
A compound that disables cancer cells, an artificial cornea, the world’s first bone implant: 2017 saw major medical advances. We bring you the best
Israel is a powerhouse in medical innovation. We give you a dozen standouts from a field with many exciting, game-changing candidates
Israel’s pharmaceutical industry plays a significant role in helping to improve the health of Americans. Israel’s growing, and vibrant pharmaceutical sector is supported by a strong foundation of academic excellence, a highly skilled work force, renowned research and development centers, and a strong entrepreneurial spirit
The U.S. Drug Enforcement Administration labels marijuana a Schedule I narcotic, "with no currently accepted medical use and a high potential for abuse," the same classification as heroin, making cannabis more tightly controlled than cocaine and methamphetamines. This policy makes conducting marijuana research in the U.S. extremely difficult, as researchers must first obtain approval from the DEA, Food and Drug Administration, and the National Institute on Drug Abuse. Enter Israel, which has become an international leader in cannabis research, partly fueled by the world's highest percentage of financial resources devoted to research. Israel was among the first countries to legalize medical marijuana – it remains illegal for recreational use – and is one of just three countries with a government-sponsored cannabis program, along with Canada and the Netherlands. The Israeli parliament recently took steps towards legalizing the export of medical marijuana. The Israeli company Breath of Life will soon open a 1-million-square-foot grow-house and research center in southern Israel. The space will be among the largest medical cannabis growth and R&D facilities in the world, according to Viridian Capital Advisors, a financial firm focused on the cannabis market
Israel spends more on research and development as a share of its domestic resources than any other developed country
Israel's pharmaceutical and biotechnology market has a reputation for high R&D spending and an impressive international reach, with world-class export numbers and a growing market value. Pharma Technology Focus profiles this innovative market to find out the secret of its success, and challenges for the future."
We recognize that only through understanding skin diseases and their potentially devastating impact on our lives can we truly develop treatments that make a difference.
We strive to ensure the highest standards of quality, which is why all our solutions are FDA-approved pharmaceutical products that meet the FDA’s OTC standard requirements.
We believe we must always be honest with our customers, and that by being caring, open and responsive, we can create belief and trust in our company to improve treatment for all.
We are dedicated to finding a cure for chronic skin diseases, and through always listening and empathizing with patients, our research experts can innovate new treatments to enhance care.
We pride ourselves on innovating treatment formulas based on latest scientific research to offer new hope to the millions affected by skin disorders.
We are committed to finding a definitive, scientific-based treatment that will enable sufferers of skin disorders to gain peace of mind and enjoy a "new" fulfilling life, full of freedom and confidence.
Home
/
About Us
/
Press Materials